webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Amino-PEG2-propionic acid

  CAS No.: 791028-27-8   Cat No.: BADC-01160   Purity: >99.3% 4.5  

Amino-PEG2-propionic acid is a short PEG linker used in ADC synthesis to improve antibody solubility and facilitate efficient drug conjugation for enhanced therapeutic efficacy.

Amino-PEG2-propionic acid

Structure of 791028-27-8

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C7H15NO4
Molecular Weight
177.20
Shipping
Room temperature
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
3-(2-(2-Aminoethoxy)ethoxy)propanoic acid; H2N-PEG2-CH2CH2COOH
IUPAC Name
3-[2-(2-aminoethoxy)ethoxy]propanoic acid
Canonical SMILES
C(COCCOCCN)C(=O)O
InChI
InChI=1S/C7H15NO4/c8-2-4-12-6-5-11-3-1-7(9)10/h1-6,8H2,(H,9,10)
InChIKey
DEZXLFKSYRODPB-UHFFFAOYSA-N
Density
1.1±0.1 g/cm3
Solubility
10 mm in DMSO
Flash Point
154.3±23.7 °C
Index Of Refraction
1.467
Vapor Pressure
0.0±1.5 mmHg at 25°C
Appearance
White/off-white solid or liquid (may vary)
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Boiling Point
331.5±27.0 °C at 760 mmHg

Amino-PEG2-propionic acid is widely utilized in drug delivery systems due to its ability to enhance the solubility and stability of drugs. Its PEG (polyethylene glycol) linker segment allows for increased hydrophilicity, thereby improving the drug’s bioavailability and prolonging its circulation time in the bloodstream. This polymeric component is also flexible and biocompatible, reducing the potential for adverse immune responses. As a result, it facilitates the effective targeting and sustained release of therapeutic agents, making it a crucial component in the design of advanced drug delivery vehicles.

Another significant application of Amino-PEG2-propionic acid lies in bioconjugation, where it serves as a linker molecule for attaching various biomolecules. The amino group allows for covalent bonding with carboxyl groups on proteins, peptides, or other biomolecules, while the PEG chain provides the necessary flexibility and distance to minimize steric hindrance. This is especially valuable in the development of antibody-drug conjugates (ADCs), where the compound enables the attachment of cytotoxic drugs to antibodies, thereby facilitating targeted cancer therapy.

Amino-PEG2-propionic acid also plays a pivotal role in surface modification, particularly for biomedical implants and devices. By grafting this compound onto surfaces, it is possible to enhance the biocompatibility and reduce the nonspecific binding of proteins and cells. This PEGylation technique creates a hydrophilic barrier on the surface, which can significantly improve the performance and longevity of medical implants such as stents, catheters, and prosthetics. This surface modification is crucial for reducing thrombus formation and improving the overall integration of implants within the body.

Finally, in the field of diagnostics, Amino-PEG2-propionic acid is an essential component in the development of sensor technologies. The PEG spacer can be used to strategically position recognition elements such as antibodies or nucleic acids on the surface of biosensors. This spatial arrangement enhances the sensor’s sensitivity and specificity by ensuring optimal interaction with target analytes. Consequently, biosensors incorporating Amino-PEG2-propionic acid linkers are employed in a variety of diagnostic applications, including the detection of pathogens, biomarkers, and environmental contaminants.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: BCN-exo-PEG2-NH2 | Val-cit-PAB-OH | Sulfo-SPDB-DGN462 | N-Ac-Cys-MC-VC-PAB-MMAE | Methyltetrazine-PEG4-oxyamine | Methyltetrazine-PEG4-SS-NHS ester | Methyltetrazine-PEG4-hydrazone-DBCO | Methyltetrazine-PEG4-SS-PEG4-methyltetrazine | Amino-PEG5-alcohol | Amino-PEG4-propionic acid | Amino-PEG2-propionic acid
Send Inquiry
Verification code
Inquiry Basket